亚组分析和随机试验中治疗效果的异质性:临床医生的入门教程
Alexandra B Spicer1, Alexandre B Cavalcanti2, Fernando G Zampieri2,3
1Department of Medicine: Allergy, Pulmonary and Critical Care Division; UW School of Medicine and Public Health.
Current opinion in critical care
|August 16, 2024
概括
从随机试验中识别治疗效果的患者异质性对于个性化护理至关重要. 超越子组分析的先进方法显示出希望,但需要进一步验证才能在临床实践中实施.
科学领域:
- 关键护理医学 关键护理医学
- 临床试验方法论 临床试验方法论
- 生物统计学 生物统计学
背景情况:
- 大多数重症监护随机临床试验 (RCT) 报告的整体结果中立,可能掩盖了患者的不同反应.
- 个性化护理策略正在出现,这是由于需要在临床实践中解决异质治疗效应 (HTE) 的需求.
研究的目的:
- 审查在RCT中估计HTE的方法方法.
- 讨论未来将HTE发现应用于患者护理的方向.
主要方法:
- 传统子组分析的概述.
- 探索先进的方法,包括亚表型,风险建模和效果建模.
- 讨论当前的局限性和未来的验证需求和指导方针.
主要成果:
- 尽管有局限性,传统的子组分析仍然很普遍.
- 在二次分析中,HTE的新方法越来越多地被使用,提供了有价值的见解.
- 需要进一步的模拟研究和指导方针,以建立可靠的临床使用验证.
结论:
- 在传统的子组方法之外,人们对在RCT中识别HTE越来越感兴趣.
- 这些先进的方法显示出对临床试验结果的设计,解释和实施的前景.
- 在临床广泛采用之前,在未来的研究中进行前性验证至关重要.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
164
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
164
Randomized Experiments
6.8K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
6.8K
Hazard Ratio
103
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
103
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Statistical Significance
20.1K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
20.1K
Analysis of Population Pharmacokinetic Data
241
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
241


